Abstract
The aim of this work is to obtain the bioactive compounds in hydroalcoholic extracts of hawthorn (Crataegus oxyacantha, Fam. Rosaceae), chokeberry (Aronia melanocarpa, Fam. Rosaceae), rosehip (Rosa canina, Fam. Roseaceae) and bilberry (Vaccinium myrtillus L., Fam. Ericaceae) by means of membrane separation process. Fruit extracts were processed by microfiltration at ambient temperature and the bioactive compounds were subsequently characterized. The microfiltration of plant extracts led to the concentration of biologically active compounds including polyphenols, procyanidins, flavanols, and their separation from lower molecular weight compounds (amino acids, monosaccharides etc.), passed into the microfiltration permeate solutions. To investigate the antioxidant activity of each plant extract, cupric ion reduction antioxidant capacity (CUPRAC) spectrophotometric methodology was employed.
Keywords: Microfiltration, hawthorn, bilberry, chokeberry, rosehip, bioactive compounds, antioxidant activity.
Current Bioactive Compounds
Title:The Bioactive Compounds Obtained from Hawthorn, Chokeberry, Rosehip and Bilberry by Microfiltration
Volume: 9 Issue: 2
Author(s): Mihaela Pascu (Neagu), Daniela - Elena Pascu, Gina Alina Traistaru, Andrei A. Bunaciu and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Microfiltration, hawthorn, bilberry, chokeberry, rosehip, bioactive compounds, antioxidant activity.
Abstract: The aim of this work is to obtain the bioactive compounds in hydroalcoholic extracts of hawthorn (Crataegus oxyacantha, Fam. Rosaceae), chokeberry (Aronia melanocarpa, Fam. Rosaceae), rosehip (Rosa canina, Fam. Roseaceae) and bilberry (Vaccinium myrtillus L., Fam. Ericaceae) by means of membrane separation process. Fruit extracts were processed by microfiltration at ambient temperature and the bioactive compounds were subsequently characterized. The microfiltration of plant extracts led to the concentration of biologically active compounds including polyphenols, procyanidins, flavanols, and their separation from lower molecular weight compounds (amino acids, monosaccharides etc.), passed into the microfiltration permeate solutions. To investigate the antioxidant activity of each plant extract, cupric ion reduction antioxidant capacity (CUPRAC) spectrophotometric methodology was employed.
Export Options
About this article
Cite this article as:
(Neagu) Pascu Mihaela, Pascu Daniela - Elena, Traistaru Alina Gina, Bunaciu A. Andrei and Aboul-Enein Y. Hassan, The Bioactive Compounds Obtained from Hawthorn, Chokeberry, Rosehip and Bilberry by Microfiltration, Current Bioactive Compounds 2013; 9 (2) . https://dx.doi.org/10.2174/22115528112019990008
DOI https://dx.doi.org/10.2174/22115528112019990008 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Agents Targeting Nitric Oxide
Current Vascular Pharmacology Synthesis and Pancreatic Lipase Inhibitory Activity of Phenacyl Esters of N-Aroyl Amino Acids
Current Enzyme Inhibition Patented Aptamers for C-Reactive Protein Detection: A Review About their Use in Clinical Diagnostics
Recent Patents on DNA & Gene Sequences Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology Anti-Inflammatory Therapeutic Approaches to Reduce Acute Atherosclerotic Complications
Current Pharmaceutical Biotechnology DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
CNS & Neurological Disorders - Drug Targets Flavonoids in Human Health: From Structure to Biological Activity
Current Nutrition & Food Science Fetzima (levomilnacipran), a Drug for Major Depressive Disorder as a Dual Inhibitor for Human Serotonin Transporters and Beta-Site Amyloid Precursor Protein Cleaving Enzyme-1
CNS & Neurological Disorders - Drug Targets Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases
Current Genomics Prebiotic Carbohydrates for Therapeutics
Endocrine, Metabolic & Immune Disorders - Drug Targets The Pathophysiology of Heart Failure in Children: The Basics
Current Cardiology Reviews Heart Failure Pharmacotherapy: Differences Between Adult and Paediatric Patients
Current Medicinal Chemistry Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design Chymase Inhibitor As a Novel Therapeutic Strategy for Anti-Vascular Remodeling
Vascular Disease Prevention (Discontinued) Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Current Pharmaceutical Design Nocturnal Blood Pressure Abnormalities in Obstructive Sleep Apnea - Clinical Predictors
Current Respiratory Medicine Reviews Endothelial Dysfunction and Coronary Artery Spasm
Current Drug Targets - Cardiovascular & Hematological Disorders Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases
Current Pharmaceutical Design Antibiotics with Antiviral and Anti-Inflammatory Potential Against Covid-19: A Review
Current Reviews in Clinical and Experimental Pharmacology